Endogenex PULSE Registry: Tracking long-term outcomes
Part of Hormones & metabolism clinical trials.
This registry collects information from people with type 2 diabetes who have already been treated with the Endogenex System. It helps researchers learn how the treatment works over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- You have already been treated with the Endogenex System.
- You agree to be part of the registry and share your health information.
- You are willing and able to attend follow-up study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial registry collects information about people living with type 1 diabetes to help researchers better understand the condition. It may help by allowing future studies and improving how care is studied and planned.
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
This study tests a procedure called pulsENDO that uses pulses of energy in the upper intestine to improve blood sugar control in people with type 2 diabetes. It might help you manage your diabetes better.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This is a research registry that collects information from people who have diabetes (high blood sugar on tests or based on diabetes treatment). It may help researchers understand diabetes patterns in a real-world healthcare system.
This study is a diabetes registry that collects health and blood information to learn what “biomarkers” (measurable signs in the body) can tell us about diabetes and related conditions. It may help researchers better understand diabetes and possibly improve future testing or care.
Hear when a new Type2diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.